Q1 2020 Holdings
Filed 2020-05-15 | 38 holdings | $275.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $63.7M | 585,000 | 23.1% |
| Codexis Inc(CDXS) | COM | 192005106 | $56.6M | 5,073,780 | 20.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $38.0M | 1,070,000 | 13.8% |
| Caredx Inc(CDNA) | COM | 14167L103 | $28.3M | 1,294,335 | 10.3% |
| Alector Inc(ALEC) | COM | 014442107 | $26.0M | 1,076,039 | 9.4% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $23.5M | 2,468,571 | 8.5% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $22.0M | 793,125 | 8.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $9.7M | 500,000 | 3.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $7.2M | 289,395 | 2.6% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $90.6K | 1,550,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $65.5K | 670,000 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $56.6K | 2,550,000 | 0.0% |
| Bluebird BIO Inc | COM | 09609G100 | $50.8K | 1,105,000 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $47.6K | 3,478,388 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $46.6K | 995,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $30.8K | 980,000 | 0.0% |
| Twist Bioscience Corp(TWST) | COM | 90184D100 | $30.6K | 1,000,000 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $28.9K | 1,319,536 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $25.5K | 1,455,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $18.7K | 2,971,034 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $15.3K | 300,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $14.4K | 1,209,285 | 0.0% |
| Genmark Diagnostics Inc(GNMK) | COM | 372309104 | $13.9K | 3,365,000 | 0.0% |
| Gritstone Oncology Inc(2JQ) | COM | 39868T105 | $13.2K | 2,270,000 | 0.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $13.1K | 175,000 | 0.0% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $11.3K | 266,430 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $11.1K | 385,000 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $11.0K | 1,125,000 | 0.0% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $10.0K | 1,095,075 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $9.8K | 190,000 | 0.0% |
| Bristol-Myers Squibb Co(BMY-R) | RIGHT | 110122157 | $9.5K | 2,500,000 | 0.0% |
| Sangamo Therapeutics Inc(SGMO) | COM | 800677106 | $9.3K | 1,455,000 | 0.0% |
| Illumina Inc(ILMN) | COM | 452327109 | $8.2K | 30,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $7.3K | 975,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $5.8K | 140,000 | 0.0% |
| Dermtech Inc(DMTKQ) | COM | 24984K105 | $5.6K | 571,713 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $3.4K | 75,000 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $2.7K | 120,000 | 0.0% |